In mammals, DNA methylation occurs mainly at CpG dinucleotides. Methylation of the promoter suppresses gene expression, but the functional role of gene-body DNA methylation in highly expressed genes has yet to be clarified. Here we show that, in mouse embryonic stem cells, Dnmt3b-dependent intragenic DNA methylation protects the gene body from spurious RNA polymerase II entry and cryptic transcription initiation. Using different genome-wide approaches, we demonstrate that this Dnmt3b function is dependent on its enzymatic activity and recruitment to the gene body by H3K36me3. Furthermore, the spurious transcripts can either be degraded by the RNA exosome complex or capped, polyadenylated, and delivered to the ribosome to produce aberrant proteins. Elongating RNA polymerase II therefore triggers an epigenetic crosstalk mechanism that involves SetD2, H3K36me3, Dnmt3b and DNA methylation to ensure the fidelity of gene transcription initiation, with implications for intragenic hypomethylation in cancer.

Intragenic DNA methylation prevents spurious transcription initiation.

Neri, F;RAPELLI, STEFANIA;KREPELOVA, ANNA;INCARNATO, DANNY;BASILE, GIULIA;MALDOTTI, MARA;ANSELMI, Francesca;OLIVIERO, Salvatore
Last
2017-01-01

Abstract

In mammals, DNA methylation occurs mainly at CpG dinucleotides. Methylation of the promoter suppresses gene expression, but the functional role of gene-body DNA methylation in highly expressed genes has yet to be clarified. Here we show that, in mouse embryonic stem cells, Dnmt3b-dependent intragenic DNA methylation protects the gene body from spurious RNA polymerase II entry and cryptic transcription initiation. Using different genome-wide approaches, we demonstrate that this Dnmt3b function is dependent on its enzymatic activity and recruitment to the gene body by H3K36me3. Furthermore, the spurious transcripts can either be degraded by the RNA exosome complex or capped, polyadenylated, and delivered to the ribosome to produce aberrant proteins. Elongating RNA polymerase II therefore triggers an epigenetic crosstalk mechanism that involves SetD2, H3K36me3, Dnmt3b and DNA methylation to ensure the fidelity of gene transcription initiation, with implications for intragenic hypomethylation in cancer.
2017
543
2
72
77
https://www.nature.com/nature/journal/v543/n7643/full/nature21373.html
Epigenetic, mediazione DNA, trascrizione
Neri, F; Rapelli, S; Krepelova, A; Incarnato, D; Parlato, C; Basile, G; Maldotti, M; Anselmi, F; Oliviero, S.
File in questo prodotto:
File Dimensione Formato  
Neri et al FORM.pdf

Open Access dal 02/09/2017

Descrizione: articolo principale
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 593.83 kB
Formato Adobe PDF
593.83 kB Adobe PDF Visualizza/Apri
nature21373_compressed.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 5.01 MB
Formato Adobe PDF
5.01 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1634241
Citazioni
  • ???jsp.display-item.citation.pmc??? 344
  • Scopus 496
  • ???jsp.display-item.citation.isi??? 466
social impact